ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BTG Btg Plc

840.00
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Btg Plc LSE:BTG London Ordinary Share GB0001001592 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 840.00 839.00 840.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Btg Share Discussion Threads

Showing 4151 to 4169 of 6225 messages
Chat Pages: Latest  177  176  175  174  173  172  171  170  169  168  167  166  Older
DateSubjectAuthorDiscuss
06/10/2016
08:36
All cash in the bank.I wonder if the next bolt on might be sterling based.Any candidates?
fhmktg
06/10/2016
08:31
CT - if Varithena sales hit £2m, if my memory serves me correctly, that would be a near doubling of sales!! So I think it will be less than that, BUT I still don't quite get your point as BTG have maintained all along the 2016-2017 will be an inflexion point, from static sales to growing sales, the bigger growth numbers as I understand it are not anticipated until 2017-2018 and beyond.
BTG clearly still believe in Varithena, check out Louise's comments in the recent magazine article, I though they were encouraging. And, they are investing in a Canadian launch - why bother wth that if the product is floundering?
All in all, I think this is the best news we could have anticipated. I'm happy.

spyder
06/10/2016
07:59
If unsure then?
bill hunt
06/10/2016
07:55
Will not surprise me if varithena revenue for first half is less than £2m.

And what about expiry of Btg patent in dec 2016 on abiraterone? The combination patent out until 2026 is owned by j&j.

cockneytrader
06/10/2016
07:47
Also Varithena also ready for uptake in Canada , so though it is slow it is starting to gain coverage.

Overall a steady set of results , giving the company the strength to do an earning enhancing deal in the near term .

bargainbob
06/10/2016
07:15
As expected. Varithena sales show gradual increase. Gradual means weak in business talk, hardly the strong growth as expected in 2016/17.
cockneytrader
04/10/2016
15:11
Traders heaven today!
fhmktg
04/10/2016
12:28
hope it shows potential to retain the £7 level this week
bargainbob
04/10/2016
10:16
Close period update Thursday, fingers crossed!
fhmktg
26/9/2016
16:09
No. It completed Phase III trials in Europe with good data, but was never put forward for approval.
cockneytrader
26/9/2016
15:48
Is Varithena available in UK? On NHS or Private?
jadeticl3
23/9/2016
15:50
Great write up.
bargainbob
23/9/2016
13:16
Message getting out?
fhmktg
23/9/2016
11:19
What a cracking read CT, thanks for posting it.That should cause some re-thinking in potential investors.Has this been placed ahead of the announcement that the inflexion point has been reached with Varithena, or to plug any market traction to a further period of low income?The comments on patient and clinician feedback are particularly welcome.
fhmktg
23/9/2016
10:54
an excellent overview review of btg now on their website. still think varithena will be a problem in the short term.
cockneytrader
21/9/2016
17:26
Oh post 4102
bargainbob
21/9/2016
17:25
Invesco modestly increasing.Optimism or a whisper?
fhmktg
19/9/2016
14:37
Bargainbob. 'However the city investors ...' That much we know for certain!
tratante
17/9/2016
16:10
Needs to show good news on varithena before any take over. However the city investors will know months and maybe years before us.
bargainbob
Chat Pages: Latest  177  176  175  174  173  172  171  170  169  168  167  166  Older

Your Recent History

Delayed Upgrade Clock